Morgane Stouvenot

Risk factors for EUS-guided radiofrequency ablation adverse events in patients with pancreatic neoplasms: a large national French study (RAFPAN study)

Bertrand Napoléon, Andrea Lisotti, Fabrice Caillol et al. · Gastrointestinal Endoscopy · 2023 · 42 citations

Medicine, Oncology, Surgery +14

Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma

Stéfano Kim, Aurélia Meurisse, Laurie Spehner et al. · Therapeutic Advances in Medical Oncology · 2020 · 34 citations · Full text

Medicine, Clinical Sciences, Oncology +10

Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO – PRODIGE 82)

Angélique Vienot, Marion Jacquin, Magali Rebucci-Peixoto et al. · BMC Cancer · 2023 · 22 citations · Full text

Life Sciences, Immunology, Oncology +17

<scp>FOLFIRI</scp> plus <scp>BEvacizumab</scp> or <scp>aFLIbercept</scp> after <scp>FOLFOX</scp>‐bevacizumab failure for <scp>COlorectal</scp> cancer (<scp>BEFLICO</scp>): An <scp>AGEO</scp> multicenter study

Cécile Torregrosa, Simon Pernot, Pauline Vaflard et al. · International Journal of Cancer · 2022 · 11 citations · Full text

Medicine, Oncology, Pharmacotherapy +10